Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17477349

Download in:

View as

General Info

PMID
17477349